SERPINB2 and breast cancer: There is evidence that PAI-2 may block uPA-mediated proteolysis and is inversely correlated with tumour progression of nonsmall cell lung carcinomas and neuroendocrine lung tumours (Robert et al, 1999) and breast cancer (Borstnar et al, 2002).